IRIS
MILANESE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.189
Totale 13.189
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.189
Totale 13.189
Salva come PNG Salva come JPEG
Città #
Genova 9.343
Genoa 1.882
Rapallo 1.492
Vado Ligure 432
Bordighera 40
Totale 13.189
Salva come PNG Salva come JPEG
Nome #
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 159
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 159
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 155
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 152
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 148
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 147
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 141
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 141
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 133
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 130
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 128
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 126
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 126
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 125
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 124
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 124
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 121
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 121
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 119
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 119
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 119
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 118
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 116
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 116
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 113
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 112
Role of calpain-1 in the early phase of experimental ALS 111
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 110
Synthesis and evaluation of resins bearing substrate-like inhibitor functions for capturing copper amine oxidases 109
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 109
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 107
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 107
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 106
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 103
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 103
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 103
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 102
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 102
A New Function for Glycine GLYT2 Transporters: Stimulation of GABA Release from Cerebellar Nerve Terminals Through GAT-1 Transporter Reversal and Ca2+-Dependent Anion Channels 101
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 101
Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synapticplasticity, and visual functions in a mouse model of Down syndrome 100
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 99
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 99
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 98
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 98
Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice 98
Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress 97
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 96
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 96
Proteomic analysis of gliosomes from mouse brain: identification and investigation of glial membrane proteins 95
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 95
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury 94
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 93
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 93
Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia 93
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 92
Diabetic neuropathic pain: a role for testosterone metabolites 91
Metabotropic glutamate receptor 5 as a potential target in ALS 91
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 90
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 90
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization 89
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 88
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 87
Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C properties 86
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 86
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis 85
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 85
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 84
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 82
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 81
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 81
Targeting group i metabotropic glutamate receptors in experimental als. 81
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of wobbler mice, a model of motor neuron disease. 80
GLUTAMATE NEUROTRANSMISSION IS MODIFIED IN THE SOD1/G93A MOUSE MODEL OF ALS 80
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 80
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 80
Cognitive impairment in Gdi1 deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training 80
The novel antidepressant agomelatine reduces release of glutamate and related presynaptic mechanisms in rat hippocampus 79
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 79
Ketamine restores changes in glutamate release, dendrite morphology and BDNF trafficking in the hippocampus of rats vulnerable to chronic mild stress 79
Presynaptic mechanisms mediating the increase of glutamate release induced by acute stress in prefrontal cortex 78
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 78
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 77
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 77
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 76
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 74
The impact of stress and glucocorticoids on glutamate synapses in cerebral cortex 73
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 73
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophjagic flux. 72
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 72
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 72
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 72
Reducing excitotoxicity knocking down mGluR1: prolonged survival and improved symptomatology of SOD1/G93A mouse model of ALS 71
Mesemchymal stem cells systemically administered in symptomatic mutant SOD1-G93A mice ameliorate survival and motor abilities 71
Partial deletion of mGluR1 receptors prolongs life span and ameliorates motor skills and biochemical and cellular parameters in a mouse model of experimental ALS 70
G93A mutated SOD1-linked murine ALS produces abnormal exocytotic release of glutamate 70
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 70
Behavioural stress and acute corticosterone modify the readily releasable pool of vesicles in glutamatergic terminals of prefrontal and frontal cortex 69
Regulation of glutamate transporter (EAAT-2) in rat retina under ischemia/reperfusion 69
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 69
Totale 9.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.642
article - articoli 22.031
book - libri 743
conference - conferenze 19.868
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.916 0 0 121 161 213 355 456 183 265 646 386 130
2020/20211.042 53 115 73 54 83 79 85 117 95 109 82 97
2021/20221.900 37 119 108 191 79 148 123 470 107 173 69 276
2022/20231.838 187 169 23 206 274 289 12 116 295 14 212 41
2023/20241.510 50 175 49 178 124 302 119 67 65 70 108 203
2024/2025569 218 307 44 0 0 0 0 0 0 0 0 0
Totale 13.754